Zydus Lifesciences Ltd., a Canadian pharmaceutical manufacturer, announced on Friday that the United States Food and Drug Administration (USFDA) has granted final approval for the production and distribution of Tavaborole Topical Solution 5%. According to the company’s exchange filing, Tavaborole topical solution is indicated for the treatment of fungal toenail infections, infections that can cause […]
Continue Reading
The US Justice Department is attempting to persuade a federal appeals court or possibly the US Supreme Court to put on hold a judge’s decision halting the government’s approval of the abortion medication mifepristone, which is used in more than half of all abortions carried out in the United States. Experts in the field of […]
Continue Reading
As per a financial exchange documenting, Zydus Lifesciences Restricted, previously Cadila Medical services Restricted, has gotten endorsement from the US wellbeing controller to showcase a conventional item. In a BSE statement, the company said that Zydus has received final approval from the United States Food and Drug Administration (USFDA) for levothyroxine sodium for injection, 100 […]
Continue Reading
The US FDA granted Acadia Pharmaceuticals’ DAYBUE (trofinetide) approval for the treatment of Rett syndrome in adults and children over the age of two last Friday. DAYBUE is the first and only medication approved for the treatment of Rett syndrome. Acadia and the Rett community have reached a significant turning point today. Steve Davis, CEO […]
Continue Reading
The US Food and Medication Organization declared its ultimate choice to pull out its endorsement of Makena, a medication supported over 10 years prior to lessen the gamble of preterm birth that had been the main drug endorsed for the condition. The FDA says that the medication isn’t successful and that the advantages of taking […]
Continue Reading
After Granules India received FDA approval for Gabapentin Tablets, the company’s share price fell slightly in early trading on March 29, 2023. In its exchanges filing, Granules India stated that the US Food and Drug Administration (US FDA) had approved its abbreviated new drug application (ANDA) for Gabapentin tablets USP, 600 mg and 800 mg. […]
Continue Reading
Incyte Corp. reported that the monoclonal antibody Zynyz had received expedited approval from the U.S. health regulator for the treatment of an aggressive and rare adult skin cancer. The treatment was approved by the Food and Drug Administration of the United States for patients with Merkel cell carcinoma (MCC) whose cancer has recurred or spread […]
Continue Reading
The pharmaceutical company Lupin made the announcement that its alliance partner Caplin Steriles’ multiple-dose vials of Thiamine Hydrochloride injection USP, 200 mg/2 mL (100 mg/mL) had been granted approval by the United States Food and Drug Administration (US FDA). According to IQVIA MAT for the twelve months ending December 2022, sales of Thiamine Hydrochloride Injection […]
Continue Reading
Glenmark Pharma has announced that the US Food and Drug Administration (USFDA) has granted it permission to distribute a generic version of Pfizer’s antibiotic Cleocin capsules. Clindamycin Hydrochloride Capsules with potencies of 75 mg, 150 mg, and 300 mg will be distributed in the United States by Glenmark Pharmaceuticals Inc, an Indian subsidiary. This endorsement […]
Continue Reading
The US Food and Drug Administration (FDA) has approved Amphastar Pharmaceuticals, Inc.’s New Drug Application (NDA) for naloxone hydrochloride nasal spray, 4 milligrams, to treat Opioid Overdose. Naloxone hydrochloride nasal spray 4mg is indicated for the immediate treatment of adult and pediatric patients suffering from respiratory and/or central nervous system depression as a result of […]
Continue Reading